Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mito Tariveranmoshabad"'
Publikováno v:
Cell Reports, Vol 29, Iss 9, Pp 2702-2717.e7 (2019)
Summary: Although microRNAs (miRNAs) function in the control of embryonic stem cell (ESC) pluripotency, a systems-level understanding is still being developed. Through the analysis of progressive Argonaute (Ago)-miRNA depletion and rescue, including
Externí odkaz:
https://doaj.org/article/8d18ebdae34b458f9ec547a77a24f154
Autor:
Anusha Kalbasi, Mikko Siurala, Leon L. Su, Mito Tariveranmoshabad, Lora K. Picton, Pranali Ravikumar, Peng Li, Jian-Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah V. Kremer, Amy L. Sun, Sofia Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C. Rommel, Enrico Radaelli, Regina M. Young, Warren J. Leonard, Antoni Ribas, Carl H. June, K. Christopher Garcia
Publikováno v:
Nature, vol 607, iss 7918
Synthetic receptor signalling has the potential to endow adoptively transferred T cells with new functions that overcome major barriers in the treatment of solid tumours, including the need for conditioning chemotherapy1,2. Here we designed chimeric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54e5dcbbb93da075e396a640fe01dad1
https://escholarship.org/uc/item/8sr3z3wt
https://escholarship.org/uc/item/8sr3z3wt
Autor:
Anusha Kalbasi, Mikko Siurala, Leon L. Su, Mito Tariveranmoshabad, Lora K. Picton, Pranali Ravikumar, Peng Li, Jian-Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah V. Kremer, Amy L. Sun, Sofia Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C. Rommel, Enrico Radaelli, Regina M. Young, Warren J. Leonard, Antoni Ribas, Carl H. June, K. Christopher Garcia
Publikováno v:
Nature. 612:E10-E10
Autor:
Katie M. Campbell, Justin Saco, Egmidio Medina, Meelad Amouzgar, Shannon M. Pfeiffer, Cynthia R. Gonzalez, Gabriela Steiner, Ameya Champhekar, Cristina Puig Saus, Jesse Zaretsky, Gabriel Abril Rodriguez, Agustin Vega-Crespo, Ignacio Baselga Carretero, Mito Tariveranmoshabad, Anusha Kalbasi, Christine Spencer, Zachary L. Skidmore, Malachi Griffith, Obi L. Griffith, Daniel K. Wells, Antoni Ribas
Publikováno v:
Cancer Research. 82:3818-3818
Introduction: Loss-of-heterozygosity (LOH) events in chromosome 6p, comprising the human leukocyte antigen (HLA) genes, have been reported in about 10% of cutaneous melanoma (compared to 20-40% of squamous cell carcinomas), while copy number gains in
Autor:
Mito Tariveranmoshabad, Leon L. Su, Amy L. Sun, Lora K. Picton, Antoni Ribas, K. Christopher Garcia, Anusha Kalbasi
Publikováno v:
Cancer Research. 82:3605-3605
Background: Orthogonal cytokine-receptor pairs allow selective in vivo manipulation of T cells after adoptive cell therapy (ACT) of cancer. Using mouse models, we previously described a chimeric orthogonal receptor (o9R) comprised of an orthogonal IL
Autor:
Jie Deng, Scott C. Chin, Mito Tariveranmoshabad, Danielle S. Graham, Hailey R. Lee, Marisol Quintero, Dorthe Schaue, Anusha Kalbasi
Publikováno v:
Cancer Research. 82:3446-3446
Background: Undifferentiated pleomorphic sarcoma (UPS) is a common aggressive sarcoma subtype for which existing therapies are ineffective. Immune checkpoint blockade (ICB) is effective in a minority of patients whose tumors harbor a pre-existing lym
Autor:
Christine Nguyen, Davis Y. Torrejon, Jesse M. Zaretsky, Antoni Ribas, Robert Damoiseaux, Kevin Hakimi, Katie M. Campbell, Mito Tariveranmoshabad, Giulia Parisi, Daniel E. Speiser, Daniel Shin, Anusha Kalbasi, Ameya Champekar, Marisol Quintero, Pedro P. López-Casas, Juan M. Funes, Agustin Vega-Crespo, Sarah Kremer
Publikováno v:
Sci Transl Med
Defects in tumor-intrinsic interferon (IFN) signaling result in failure of immune checkpoint blockade (ICB) against cancer, but these tumors may still maintain sensitivity to T cell–based adoptive cell therapy (ACT). We generated models of IFN sign
Autor:
Christopher Garcia, AnushaGiulia Parisi, Helena Escuin-Ordenas, Mito Tariveranmoshabad, Lora Picton, Leon Su, Anusha Kalbasi, Sarah Kremer, Antoni Ribas
Publikováno v:
Cancer Research. 81:NG11-NG11
Background: Adoptive cell therapy using genetically engineered T cells - such as chimeric antigen receptor (CAR) or T cell receptor (TCR) modified T cells - is an effective therapy for patients with cancer. However, successful adoptive cell therapies
Publikováno v:
Cell reports, vol 29, iss 9
Cell reports
Cell Reports, Vol 29, Iss 9, Pp 2702-2717.e7 (2019)
Cell reports
Cell Reports, Vol 29, Iss 9, Pp 2702-2717.e7 (2019)
SUMMARY Although microRNAs (miRNAs) function in the control of embryonic stem cell (ESC) pluripotency, a systems-level understanding is still being developed. Through the analysis of progressive Argonaute (Ago)-miRNA depletion and rescue, including s